dc.contributor.author |
Meydanli, MM |
|
dc.contributor.author |
Caliskan, E |
|
dc.contributor.author |
Haberal, A |
|
dc.date.accessioned |
2022-10-19T12:19:03Z |
|
dc.date.available |
2022-10-19T12:19:03Z |
|
dc.date.issued |
2003 |
|
dc.identifier.uri |
http://hdl.handle.net/11616/84361 |
|
dc.description.abstract |
Objective: To identify predictors of adverse outcome in pregnant women at term receiving 50 mug of intravaginal misoprostol for labor induction. Study design: A prospective observational study was conducted of 720 pregnant women at term with an unfavorable cervix and a medical or obstetric indication for labor induction. All patients received 50 mug of intravaginal misoprostol every 4 h up to three doses. The primary outcome measure was "adverse outcome" defined as: neonatal death, fetal acidemia and emergent cesarean delivery performed for non-reassuring fetal heart rate tracings. A stepwise logistic regression analysis was used to identify predictors of adverse outcome. Results: Tachysystole (frequent uterine contractions) (odds ratio (OR), 3.7; 95% confidence interval (CI), 1.2-10.8) and fetal tachycardia (OR, 4.8; 95% CI, 1.4-16.2) were determined as significant predictors of adverse outcome. The specificity of the model was 94.2%, whereas the sensitivity was 20.4%. Conclusion: In the absence of tachysystole and fetal tachycardia, an uneventful delivery might be expected for women receiving 50 mug of intravaginal misoprostol. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved. |
|
dc.description.abstract |
C1 SSK Matern & Womens Hlth Teaching Hosp, Ankara, Turkey. |
|
dc.source |
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY |
|
dc.title |
Prediction of adverse outcome associated with vaginal misoprostol for |
|
dc.title |
labor induction |
|